Publication | Closed Access

Portulaca oleracea extracts and their active compounds ameliorate inflammatory bowel diseases in vitro and in vivo by modulating TNF-α, IL-6 and IL-1β signalling

InflammationAnti-inflammatoryMucosal ImmunologyMedicineImmunologyImmune RegulationPathologyActive CompoundsIl-1β SignallingPharmacologyInflammatory DiseaseInflammatory Bowel Diseases